RGS2 deficiency in mice does not affect platelet thrombus formation at sites of vascular injury

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 2, 2012, Pages 309-311

  Banno, F ^a   Nojiri, T ^a   Matsumoto, S ^a   Kamide, K ^a,b   Miyata, T ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RGS2 PROTEIN;

ANIMAL CELL; ARTERIOLE; ARTERY INJURY; CONTROLLED STUDY; LETTER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SHEAR RATE; THROMBOCYTE AGGREGATION; THROMBOGENESIS; WILD TYPE;

ANIMALS; BLOOD PLATELETS; HEMOSTASIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RGS PROTEINS; THROMBOSIS; VASCULAR SYSTEM INJURIES;

EID: 84856557705     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2011.04575.x     Document Type: Letter

References (14)

1. Riddle EL, Schwartzman RA, Bond M, Insel PA. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res 2005; 96: 401-11.
2. Bansal G, Druey KM, Xie Z. R4 RGS proteins: regulation of G-protein signaling and beyond. Pharmacol Ther 2007; 116: 473-95.
3. Roy AA, Baragli A, Bernstein LS, Hepler JR, Hebert TE, Chidiac P. RGS2 interacts with Gs and adenylyl cyclase in living cells. Cell Signal 2006; 18: 336-48.
4. Woulfe DS. Platelet G protein-coupled receptors in hemostasis and thrombosis. J Thromb Haemost 2005; 3: 2193-200.
5. Offermanns S. Activation of platelet function through G protein-coupled receptors. Circ Res 2006; 99: 1293-304.
6. Signarvic RS, Cierniewska A, Stalker TJ, Fong KP, Chatterjee MS, Hess PR, Ma P, Diamond SL, Neubig RR, Brass LF. RGS/Gi2alpha interactions modulate platelet accumulation and thrombus formation at sites of vascular injury. Blood 2010; 116: 6092-100.
7. Noé L, Di Michele M, Giets E, Thys C, Wittevrongel C, De Vos R, Overbergh L, Waelkens E, Jaeken J, van Geet C, Freson K. Platelet Gs hypofunction and abnormal morphology resulting from a heterozygous RGS2 mutation. J Thromb Haemost 2010; 8: 1594-603.
8. Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, Bai D, Houston FP, Whishaw IQ, Mariathasan S, Sasaki T, Wakeham A, Ohashi PS, Roder JC, Barnes CA, Siderovski DP, Penninger JM. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 2000; 97: 12272-7.
9. Matsumoto S, Kamide K, Banno F, Inoue N, Mochizuki N, Kawano Y, Miyata T. Impact of RGS2 deficiency on the therapeutic effect of telmisartan in angiotensin II-induced aortic aneurysm. Hypertens Res 2010; 33: 1244-9.
10. Kim SD, Sung HJ, Park SK, Kim TW, Park SC, Kim SK, Cho JY, Rhee MH. The expression patterns of RGS transcripts in platelets. Platelets 2006; 17: 493-7.
11. Sudo T, Ito H, Kimura Y. Genetic strain differences in platelet aggregation of laboratory mice. Thromb Haemost 2006; 95: 159-65.
12. Tabuchi A, Taniguchi R, Takahashi K, Kondo H, Kawato M, Morimoto T, Kimura T, Kita T, Horiuchi H. Action of aspirin on whole blood-aggregation evaluated by the screen filtration pressure method. Circ J 2008; 72: 420-6.
13. Banno F, Kokame K, Okuda T, Honda S, Miyata S, Kato H, Tomiyama Y, Miyata T. Complete deficiency in ADAMTS13 is prothrombotic, but it alone is not sufficient to cause thrombotic thrombocytopenic purpura. Blood 2006; 107: 3161-6.
14. Banno F, Chauhan AK, Kokame K, Yang J, Miyata S, Wagner DD, Miyata T. The distal carboxyl-terminal domains of ADAMTS13 are required for regulation of in vivo thrombus formation. Blood 2009; 113: 5323-9.